Treatment

LCB02A clinical trials

1 indexed studies · 1 currently recruiting

Not yet recruitingPHASE1, PHASE2
A Study to Evaluate Claudin 18.2-Directed ADC LCB02A in Advanced Solid Tumors
This study is testing a new drug, LCB02A, for people with advanced cancers that haven't responded to usual treatments. It aims to find the right dose and see if it helps shrink tumors by targeting a specific protein called Claudin 18.2.
For: Advanced Solid Tumors
United States · Canada · South Korea